TRACKER is a biobank dedicated to advancing lung cancer research. By providing high-quality, longitudinally collected biospecimens and comprehensive clinical data, TRACKER empowers researchers to uncover new therapeutic targets, understand treatment resistance, and improve patient outcomes through collaborative science.
Company Details
- Founded
- -
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.trackerbiobank.com
- Keywords
- Empowering research breakthroughs with Australia’s first biobank for advanced lung cancer samples..
- Competitors
- Adelaide Interventional Pulmonology and Pleural Group, School of Bronchoscopy, Millennium Science, One Health Biobank Foundation, Lung Foundation Australia, Australian CTE Biobank, Olivia Newton-John Cancer Research Institute, LifeLUNG, GenTree Community Biobank, Liverpool University Biobank (LUB).
Tracker Biobank Questions
Tracker Biobank's website is http://www.trackerbiobank.com
Tracker Biobank's LinkedIn profile is https://www.linkedin.com/company/tracker-biobank
Tracker Biobank's industry is
Research Services
Tracker Biobank's top competitors are
Adelaide Interventional Pulmonology And Pleural Group,
School Of Bronchoscopy,
Millennium Science,
One Health Biobank Foundation,
Lung Foundation Australia,
Australian Cte Biobank,
Olivia Newton-John Cancer Research Institute,
Lifelung,
Gentree Community Biobank,
Liverpool University Biobank (Lub).
Tracker Biobank's categories are Research Services
Tracker Biobank's founding year is 2023
